You are here:Home-Chemical Inhibitors & Agonists-Immunology/Inflammation-PD-1/PD-L1-CA-170
CA-170

Chemical Structure : CA-170

CAS No.: 1673534-76-3

CA-170 (CA170)

Catalog No.: PC-72654Not For Human Use, Lab Use Only.

CA-170 (CA170) is a first-in-class, orally available, tripeptide small-molecule dual antagonist of VISTA/PD-L1, important negative checkpoint regulators of immune activation.

Packing Price Stock Quantity
5 mg $248 In stock
10 mg $378 In stock
25 mg $628 In stock
100 mg $1380 In stock
200 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

CA-170 (CA170) is a first-in-class, orally available, tripeptide small-molecule dual antagonist of VISTA/PD-L1, important negative checkpoint regulators of immune activation.
CA-170 demonstrated dose-dependent enhancement in the proliferation of PD-L1, PD-L2, and VISTA-inhibited T lymphocytes, and exhibited antitumor effects similar to those of antibodies, including tumor shrinkages and prolonged stable disease without adverse effects.
CA170 has excellent oral bioavailability, a relatively short half-life, and it can dose-dependently enhance the proliferation of T lymphocytes due to its ability to inhibit VISTA.
In syngeneic murine tumor models, the antitumor effects of CA170 were similar to VISTA-blocking antibody.
CA170 was well tolerated in phase I clinical trials and is undergoing phase II clinical trials for lung cancer, head and neck/oral cavity cancer, MSI-H positive cancers, and Hodgkin lymphoma.

Physicochemical Properties

M.Wt 360.33
Formula C12H20N6O7
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

50 mM in DMSO (18.1 mg/mL)

Chemical Name/SMILES

(((S)-3-amino-1-(3-((S)-1-amino-2-hydroxyethyl)-1,2,4-oxadiazol-5-yl)-3-oxopropyl)carbamoyl)-L-allothreonine

References

1. Musielak B, et al. Molecules. 2019 Aug 1;24(15):2804.

2. Sasikumar PG, et al. Commun Biol. 2021 Jun 8;4(1):699.

3. Li TT, et al. BMC Immunol. 2021 Aug 11;22(1):55.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: